About BioPharma

Biosimilars

A biosimilar is a biological drug that is similar to an approved biological drug and has no clinically significant differences in efficacy and safety. Biological drugs are complex compounds grown in or derived from living cell lines. Our expanding biosimilars portfolio focuses on inflammatory and immune diseases and oncology. 

Within these therapeutic areas, we have several candidates at various stages of development, reinforcing our commitment to continuous innovation in biological therapies. We are committed to providing more patients with access to affordable alternative treatment options and helping to reduce the cost burden on healthcare systems. 

Job Code:IE-NPR-2400010

Date of preparation: November 2024

This is intended for healthcare professionals in the Republic of Ireland only and contains information about Fresenius Kabi medicines. By accessing this information you are confirming you are a healthcare professional in the Republic of Ireland.

If you are a healthcare professional based in Northern Ireland please access the Fresenius Kabi UK site here for more information. www.fresenius-kabi.com/gb

If you are not a healthcare professional, please return to the Fresenius Kabi Ireland homepage where you can find more information for the public and for patients using Fresenius Kabi medicines or products.

IE-NP-2400056 November 2024

I am a healthcare professional in the Republic of Ireland I am not a healthcare professional